Susceptibility to primary biliary cirrhosis (PBC) may be partly inherited although instances of PBC within families are only infrequently described. The records of 736 patients with PBC seen over a 25 year period were examined to identify those with a positive family history. Ten patients originating from eight families were identified, giving a frequency of 1.33%. They comprised mother and daughter pairs; in two families both mother and daughter had been seen at our clinic. The daughters presented at an earlier age, median 36 years (range 24-54), than the mothers, 52 years (50-81). During follow up one daughter (45 years) and six mothers have died (range 53-81 years) and two mothers and one daughter have had a transplant aged 57, 57, and 30 years respectively. It is concluded that familial PBC is not rare, that it is related to maternally inherited factors, and that disease tends to present earlier in the second generation. (Gut 1995; 36: 615-617) 
Primary biliary cirrhosis (PBC) is considered to be an autoimmune disease as it is associated with serum anti-mitochondrial antibodies and abnormalities of the immune system. Although it is not thought to be an inherited disease, there have been a number of reports describing multiple cases of PBC occurring within a single family. 1-17 However, there has only been one recent systematic study of PBC frequency within families published as an abstract. 18 Abnormalities of immune function have also been shown in family members of patients with PBC suggesting immunogenetic susceptibility. Unaffected family members have an increased frequency of anti-mitochondrial antibodies4 and abnormal T cell function.16 19 The exact nature of the molecular basis for an inherited immunological susceptibility to PBC and its comparative importance to disease manifestation remains uncertain.
The evidence that environmental factors are important in the development of PBC is limited20 21 but such factors could also be involved in its familial occurrence.
In this report, we describe a systematic study of 736 patients with PBC who attended and were reviewed over a period of 25 years in a single unit, carried out to determine both the prevalence and pattern of familial disease.
Methods
The case records of a total of 736 patients who were referred to and reviewed at the Institute of Liver Studies, King's College Hospital from 1967 to 1992 with an established diagnosis of PBC were examined to identify those with a record of other cases of PBC within the family. The diagnosis of PBC was based on standard criteria (that is, positive anti-mitochondrial antibody, raised biliary enzymes, compatible clinical history, and liver histology). Details of presentation (mode, date, and age), autoantibodies, liver biopsy findings, follow up and outcome, presence of other diseases and family history of autoimmune disease were obtained wherever possible by interview or by informal postal questionnaire of the patients and affected family, as well as examining the case records held within our hospital and any other hospitals attended by the patient.
Results
In 10 (1.33%) of 736 patients there was a history of PBC in a family member and in two instances both affected family members had been seen at our clinic. Table I gives details of the patients, and the first patient to be seen. All had serum anti-mitochondrial antibody positivity and were mother and daughter pairs, all were white and originated from Britain. No record of affected but unrelated family members was found. All mothers and two of the daughters were cirrhotic at diagnosis; the histological stage of disease and the date of liver biopsy is shown. The daughters presented at an earlier age, median 36 years (range 24-54) than the mothers, median 52 years (range 50-81). All but three of the daughters had presented before their mothers.
Of the eight affected daughters, three were asymptomatic at presentation and were diagnosed because of the finding of abnormal liver function tests. Three others had presented with jaundice in pregnancy, one with tiredness, and one with bleeding oesophageal varices. All the mothers were symptomatic at presentation: two had tiredness, two abdominal pain, one jaundice, and three oesophageal varices. Although all the daughters had been raised by their mothers, at the time of presentation none of the daughters was living with her mother. There were records of associated thyroid disease in three patients and one had coeliac disease.
Median follow up for the daughters was 6-5 years (range 2-16) and for the mothers was 3-5 years (range 1 month-9 years). Mortality over this period comprised one daughter (aged 45 years) and six mothers, median age 72 years These genotypic associations may underly the phenotypic findings of abnormal lymphocyte function in families with PBC.16 None of our cases of familial PBC was associated with a well defined immune disorder, unlike those previously described in association with IgA deficiencyl1 or hypergammaglobulinaemia.8 Table II gives a summary of previous reports of familial cases of PBC. All our cases were female, which is consistent with the female preponderance in PBC, although affected male family members have been reported. Inheritance was maternal as in all other reported cases where it is possible to deduce inheritance; the one exception was in the family with associated hypergammaglobulinaemia (father and daughters).'1 If the inherited predisposition to PBC is truly maternal it might involve mitochondrial DNA, which is always maternally inherited or be related to non-inherited maternal HLA antigens, which have been implicated in the familial predisposition to rheumatoid arthritis.26 Inherited familial predisposition to PBC is more likely, however, to be complex and polygenic involving the interaction of a number of genes.
With respect to an environmental basis for the familial occurrence of PBC, epidemiological studies have linked development of PBC to the reservoir supplying drinking water,20 there have been reports of geographical and seasonal clustering of cases,21 and there is a report of PBC occurring in a non-related nurse of a patient with PBC.7 One suggestion is that an agent may be bacterial -that is, Escherichia coli -as there is cross reactivity between E coli antigens and anti-mitochondrial antibodies. 27 In some studies a high prevalence of E coli urinary tract infections has been found among patients with PBC.28 Whatever the nature of the agent it has always been apparent that there is a long incubation period between the exposure and manifestation of the disease. All our family pairs spent a considerable period of their lives together but presented at different stages of the disease and at different times and had not been living together for some time in the immediate past. Four pairs of mothers and daughters presented within five years of each other but the second case to present was not always at a more advanced stage of the disease. Indeed the daughter in pair no 2 presented 17 years after her mother and with stage I disease. It is noteworthy that we did not find any case of PBC occurring in non-related family members. The case of PBC in a close contact of a patient did have a family history of autoimmune disease .7 In this series all the daughters presented at a younger age than their mothers. This may be partly because of increased awareness of the disease and the greater availability of screening nowadays leading to more being found with asymptomatic disease at an earlier age. Many of the daughters, however, presented either before their mothers or had a more rapid disease progression. The daughter who had a transplant and the daughter who has died were younger than any of the mothers at death or transplantation. In addition, the other three daughters with symptomatic disease became symptomatic at a younger age than their respective mothers. Interestingly, Tong et al found the same phenomenon, where the daughter was more severely affected than her mother.5
